Vimarsana
Biggest News Aggregation in the World

Mike Carnes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mike Carnes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mike Carnes Today - Breaking & Trending Today

A repositioning of players in the MSR market is underway - Vimarsana News

A repositioning of players in the MSR market is underway

The growing role of private investors, new capital rules and industry consolidation are among the variables propelling change in the MSR market.

A repositioning of players in the MSR market is underway - Vimarsana News

A repositioning of players in the MSR market is underway

The mortgage-servicing rights (MSR) market remains robust as we turn the corner into 2024, and though it is expected to slightly underperform 2023, the market is still projected to notch healthy trading volumes in 2024 — hovering near the $1 trillion mark for the fourth year in a row, market observers forecast.

Source: yahoo.com
MSR trading should finish strong in 2023, but there are headwinds - Vimarsana News

MSR trading should finish strong in 2023, but there are headwinds

Even in this bull MSR market, there are headwinds to keep an eye on going forward: bank MSR portfolios are shrinking, IMBs are on a treadmill and there are growing concerns about future trading volumes.

GSE repurchase risk is rippling through the MSR market - Vimarsana News

GSE repurchase risk is rippling through the MSR market

Elevated buyback pressure from Fannie and Freddie is particularly acute for small, struggling lenders seeking to sell mortgage-servicing rights (MSRs).

Source: yahoo.com
Cancer Therapy Company Acquires Durham-Based Cereius | North Carolina Biotechnology Center - Vimarsana News

Cancer Therapy Company Acquires Durham-Based Cereius | North Carolina Biotechnology Center

Cereius, Inc., a biotechnology company developing therapies to treat cancer that has spread to the brain, has been acquired by San Diego-based Solve Therapeutics, Inc. (SolveTx).